Biomeme and Indical enters into an exclusive global licensing and research agreement in a joint effort to improve animal health globally.
Biomeme has developed an advanced mobile PCR detection technology that solves time-sensitive and location-sensitive problems where results need to be in real-time. Indical, with twenty years of experience animal diagnostics, will adapt the molecular point-of-need testing for veterinary applications and offer its suite of molecular and immunological testing solutions.
Read more about the exclusive partnership here.
The Board of Directors of Vimian Group AB has based on the authorisation from the Annual General Meeting on 2 June 2023, resolved on a rights issue of up to approximately SEK 1,633 million. The purpose of the Rights Issue
Read moreOn the 22 of February, the winners of the “CEO of the Year” award were announced at Kistamässan in Stockholm. The winner in the Large-Cap category was David von Laskowski, Picadeli & Greenfood Group. “CEO of the Year” has been
Read moreVegner Group Limited is a leading residential property management group in the UK with 475 employees, over 100,000 homes under management and a nationwide reach across 20 office locations. Vegner specializes in serving Residents Management Company (RMC) clients, bringing further
Read more